Quotient Sciences
Building a best-in-class pharmaceutical services business, Quotient Sciences takes an innovative approach to drug development.

Through its unique Translational Pharmaceutics platform, Quotient can accelerate the drug development process, enabling its pharmaceutical and biotech customers to reduce the time and cost of bringing a new drug to market.
DETAILS

Sector

Healthcare

Country or Region

UK

Status

Current

2019

Investment year

£120m+

Annual revenues

275+

Molecules

Related Team

Paul Armstrong